LEMAITRE VASCULAR INC - Common Stock (LMAT)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
18,810,702
Total 13F shares
18,811,526
Share change
+39,644
Total reported value
$1,264,888,648
Put/Call ratio
175%
Price per share
$67.28
Number of holders
208
Value change
+$4,977,677
Number of buys
104
Number of sells
93

Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q2 2023

As of 30 Jun 2023, LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by 208 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,811,526 shares. The largest 10 holders included BlackRock Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, Ranger Investment Management, L.P., DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and CONGRESS ASSET MANAGEMENT CO /MA. This page lists 208 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.